S. 229 · 119th Congress (2025–2027)
DTC Act of 2025
Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025
This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.
Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.
The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.
Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Show official title
A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is S. 229’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
- Sponsor
- Sen. Richard J. Durbin (D-IL)
- Cosponsors
9 cosponsors
8 original · 1 later
4 R · 4 D · 1 I
- Sen. Tammy Baldwin (D-WI)· Original · Jan 23, 2025
- Sen. Richard Blumenthal (D-CT)· Original · Jan 23, 2025
- Sen. Joni Ernst (R-IA)· Original · Jan 23, 2025
- Sen. Chuck Grassley (R-IA)· Original · Jan 23, 2025
- Sen. Angus S. King Jr. (I-ME)· Original · Jan 23, 2025
- Sen. Tina Smith (D-MN)· Original · Jan 23, 2025
- Sen. Tommy Tuberville (R-AL)· Original · Jan 23, 2025
- Sen. Peter Welch (D-VT)· Original · Jan 23, 2025
- Sen. Cindy Hyde-Smith (R-MS)· Later · Jan 28, 2025
- Policy area
- Health
- Subjects
- Administrative law and regulatory procedures
- Civil actions and liability
- Department of Health and Human Services
- Health care costs and insurance
- Marketing and advertising
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Congressional Record S337-338; Sponsor introductory remarks on measure: CR S337
Read twice and referred to the Committee on Finance.
Sources
- Congress.gov action
- Senate
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (3)
DTC Act of 2025
Display title, Short title · Introduced in Senate
Drug-price Transparency for Consumers Act of 2025
Short title · Introduced in Senate
A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.
Official title · Introduced in Senate